HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model.

AbstractPURPOSE:
Liver cancer is the second most common cause of death worldwide. This study was to investigate the SPECT/CT, ultrasound, biodistribution and therapeutic evaluation of 188Re-human serum albumin microspheres (188Re-HSAM) in the GP7TB orthotopic hepatoma rat model.
MATERIALS AND METHODS:
HSAM was labeled with 188Re by using a home-made kit and microwave system. The 188Re-HSAM was administered via intraarterial route. The in vivo distribution of 188Re-HSAM was determined by biodistribution analysis and nanoSPECT/CT system. In efficacy, tumor volumes were tracked longitudinally by three-dimensional ultrasound.
RESULTS:
The biodistribution and nanoSPECT/CT imaging showed that 188Re-HSAM could accumulate in liver and tumor. The correlation coefficient of tumor volumes done by three-dimensional ultrasound and at autopsy was 0.997. In efficacy, tumor volume in the normal saline-treated group was 1803.2 mm3 at 54 days after tumor inoculation. Tumor volumes in the 103.6 MBq and 240.5 MBq of 188Re-HSAM treated groups were 381 and 267.4 mm3 (p = 0.001 and 0.004), respectively.
CONCLUSIONS:
These results show that three-dimensional ultrasound with a high spatial resolution and contrast in soft tissue can become imaging modality in assessing tumor burden and tumor progression in an orthotopic rat model. The longitudinally therapeutic evaluation of 188Re-HSAM demonstrated dose-dependent tumor growth inhibition with increased dose in the GP7TB orthotopic hepatoma rat model.
AuthorsLiang-Cheng Chen, Ya-Jen Chang, Su-Jung Chen, Wan-Chi Lee, Chih-Hsien Chang, Te-Wei Lee, Jui-Hung Shien
JournalInternational journal of radiation biology (Int J Radiat Biol) Vol. 93 Issue 5 Pg. 477-486 (05 2017) ISSN: 1362-3095 [Electronic] England
PMID28045339 (Publication Type: Journal Article)
Chemical References
  • Capsules
  • Radioisotopes
  • Radiopharmaceuticals
  • Serum Albumin
  • Rhenium
Topics
  • Animals
  • Apoptosis (radiation effects)
  • Capsules (chemical synthesis, pharmacokinetics)
  • Carcinoma, Hepatocellular (diagnostic imaging, metabolism, radiotherapy)
  • Cell Line, Tumor
  • Injections, Intra-Arterial
  • Liver Neoplasms (diagnostic imaging, metabolism, radiotherapy)
  • Male
  • Organ Specificity
  • Radioisotopes (administration & dosage, pharmacokinetics)
  • Radiopharmaceuticals (administration & dosage, pharmacokinetics)
  • Rats, Inbred F344
  • Rhenium (administration & dosage, pharmacokinetics)
  • Serum Albumin (chemistry)
  • Single Photon Emission Computed Tomography Computed Tomography
  • Theranostic Nanomedicine
  • Tissue Distribution
  • Treatment Outcome
  • Tumor Burden (radiation effects)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: